definitely but I think big Pharma would like to control a huge percentage of manufacturing supply rather than fully outsourcing
Big Pharma without any staff, logistics exp, and manufacturing exp will have to put a larger CAPEX to sell this product resulting to unfavourable revenues and sales performance
Research/Valuation, page-28
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.01 |
Change
-0.340(4.63%) |
Mkt cap ! $2.244B | |||
| Open | High | Low | Value | Volume |
| $7.39 | $7.44 | $6.87 | $7.431M | 1.054M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3289 | $7.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.04 | 4050 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |